Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category

Results 601 - 700 of 5395 go to 1st page

first

previous 2 3 4 5 6 7 8 9 10 11 12 next

last

Title	Date	Price
Tianyin Pharmaceutical Co., Inc.-Detailed Product Pipeline	Sep 2009	£460
TapImmune, Inc.-Detailed Product Pipeline	Sep 2009	£460
Trubion Pharmaceuticals Inc.-Detailed Product Pipeline	Sep 2009	£460
Trimeris Inc-Detailed Product Pipeline	Sep 2009	£460
Targacept Inc-Detailed Product Pipeline	Sep 2009	£460
Theravance Inc-Detailed Product Pipeline	Sep 2009	£460
Targeted Genetics Corp-Detailed Product Pipeline	Sep 2009	£460
Taro Pharmaceutical Industries Ltd-Detailed Product Pipeline	Sep 2009	£460
Telik Inc-Detailed Product Pipeline	Sep 2009	£460
Teva Pharmaceutical Industries Ltd-Detailed Product Pipeline	Sep 2009	£460
Threshold Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
Tetragenex Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£460
Titan Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
Vical Inc-Detailed Product Pipeline	Sep 2009	£460
Vicor Technologies, Inc.-Detailed Product Pipeline	Sep 2009	£460
VIA Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£460
Shanxi Weiqida Pharmaceutical Co., Ltd-Company Report	Sep 2009	£460
Radius Health Inc. (formerly NuVios, Inc.)-Company Report	Sep 2009	£460
United Therapeutics Corporation-Detailed Product Pipeline	Sep 2009	£460
Vaso Active Pharmaceuticals-Detailed Product Pipeline	Sep 2009	£460
Unigene Laboratories Inc-Detailed Product Pipeline	Sep 2009	£460
Urigen Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£460
ULURU Inc-Detailed Product Pipeline	Sep 2009	£460
USANA Health Sciences Inc-Detailed Product Pipeline	Sep 2009	£460
Transdel Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£460
Symbollon Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
Santarus Inc-Detailed Product Pipeline	Sep 2009	£460
Sunesis Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
SoluBest-Company Report	Sep 2009	£460
Synta Pharmaceuticals Corp.-Detailed Product Pipeline	Sep 2009	£460
Sinobiomed Inc.-Detailed Product Pipeline	Sep 2009	£460
Senesco Technologies Inc-Detailed Product Pipeline	Sep 2009	£460
Smith & Nephew Plc-Detailed Product Pipeline	Sep 2009	£460
SIGA Technologies Inc-Detailed Product Pipeline	Sep 2009	£460
Skinvisible Inc-Detailed Product Pipeline	Sep 2009	£460
Salix Pharmaceuticals Ltd-Detailed Product Pipeline	Sep 2009	£460
Senetek Plc-Detailed Product Pipeline	Sep 2009	£460
Spherix Incorporated-Detailed Product Pipeline	Sep 2009	£460
Somaxon Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
Savient Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
Stryker Corp-Detailed Product Pipeline	Sep 2009	£460
Systagenix Wound Management-Company Report	Sep 2009	£460
Synvista Therapeutics, Inc.-Detailed Product Pipeline	Sep 2009	£460
Swiss Medica Inc-Detailed Product Pipeline	Sep 2009	£460
Sinovac Biotech Ltd-Detailed Product Pipeline	Sep 2009	£460
Samaritan Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
Spectrum Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£460
SuperGen Inc-Detailed Product Pipeline	Sep 2009	£460
StemCells Inc-Detailed Product Pipeline	Sep 2009	£460
Raazee Therapeutics (Pvt) Ltd.-Company Report	Sep 2009	£460
Quinnova Pharmaceuticals, Inc.-Company Report	Sep 2009	£460
Jenburkt Pharmaceuticals Ltd.-Company Report	Sep 2009	£455
Jemo-pharm A/S-Company Report	Sep 2009	£455
Jerini AG-Company Report	Sep 2009	£455
Jiangsu Hengrui Medicine Co., Ltd.-Company Report	Sep 2009	£455
Jiangsu Lianshui Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Jeil Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
JCR Pharmaceuticals Co., Ltd-Company Report	Sep 2009	£455
Janssen-Cilag S.p.A.-Company Report	Sep 2009	£455
Janssen Pharmaceutica N.V.-Company Report	Sep 2009	£455
Janus Pharmaceuticals Inc-Company Report	Sep 2009	£455
Japan Tobacco Inc.-Company Report	Sep 2009	£455
Jin Yang Pharmaceutical Co. Ltd-Company Report	Sep 2009	£455
JINIS Biotechnology Corporation-Company Report	Sep 2009	£455
Julphar-Company Report	Sep 2009	£455
Juste S.A.Q.F.-Company Report	Sep 2009	£455
KAI Pharmaceuticals Inc.-Company Report	Sep 2009	£455
Kaire International (Canada) Ltd-Company Report	Sep 2009	£455
JSJ Pharmaceuticals-Company Report	Sep 2009	£455
JSC Farmak International-Company Report	Sep 2009	£455
Jiwa Bio-Pharm Holdings Limited-Company Report	Sep 2009	£455
Johnson & Johnson-Therapeutic Competitors	Sep 2009	£210
JN International Medical Corporation-Company Report	Sep 2009	£455
JSC Grindeks-Company Report	Sep 2009	£455
Jagsonpal Pharmaceuticals Limited-Company Report	Sep 2009	£455
Jadran Galenski laboratorij d.d. (JGL)-Company Report	Sep 2009	£455
Intra-Cellular Therapies, Inc. (ITI)-Company Report	Sep 2009	£455
Intra Labs Pvt. Ltd.-Company Report	Sep 2009	£455
Inviragen, Inc.-Company Report	Sep 2009	£455
Ipca Laboratories Limited-Company Report	Sep 2009	£455
Ipsat Therapies Oy-Company Report	Sep 2009	£455
InterMed Discovery GmbH-Company Report	Sep 2009	£455
Intercytex-Company Report	Sep 2009	£455
Quest PharmaTech Inc. (formerly Altachem Pharma Ltd.)-Company Report	Sep 2009	£460
QuatRx Pharmaceuticals-Company Report	Sep 2009	£460
Quark Pharmaceuticals, Inc.-Company Report	Sep 2009	£460
QRxPharma Pty Ltd-Company Report	Sep 2009	£460
IRX Therapeutics, Inc.-Company Report	Sep 2009	£455
IS Pharma plc (formerly Maelor Pharmaceuticals Ltd.)-Company Report	Sep 2009	£455
Izun Pharma Ltd-Company Report	Sep 2009	£455
J.B.CHEMICALS & PHARMACEUTICALS LIMITED-Company Report	Sep 2009	£455
Jenrin Discovery, Inc.-Company Report	Sep 2009	£455
JADO Technologies GmbH-Company Report	Sep 2009	£455
ItherX, Inc.-Company Report	Sep 2009	£455
Italfarmaco S.p.A-Company Report	Sep 2009	£455
ISDIN-Company Report	Sep 2009	£455
Isotechnika Inc.-Company Report	Sep 2009	£455
Istituto Ganassini-Company Report	Sep 2009	£455
ISU ABXIS Inc. (formerly PetaGen)-Company Report	Sep 2009	£455
KAKEN PHARMACEUTICAL CO., LTD.-Company Report	Sep 2009	£455